Announcements Trials
Browse Landscape

Phase

Phase 4 1Phase 3 1

Status

Unknown 2Completed 2

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Classical hematology 2Lymphoid 1Gynecologic 1

Conditions

Anemia 2Neoplasms 1Lymphoma 1

Interventions

avatrombopag 5iron isomaltoside 1000 4hetrombopag 3ferric carboxymaltose 3Cytarabine 3eltrombopag 2Rivaroxaban 2Radiotherapy 2Meropenem 2Idarubicin 2Granulocyte Colony-Stimulating Factor 2Etoposide 2Erythropoietin 2Cyclophosphamide 2Azacitidine 2thymoglobulin 1stinging nettle lectin 1romiplostim 1raltitrexed 1peppermint oil 1pegfilgrastim 1oprelvekin 1fludarabine phosphate 1fludarabine 1ferrous succinate 1ferrous fumarate 1ferric derisomaltose 1epoetin beta 1cc-486 1Vitamin B 12 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Erythropoietin × Classical hematology × Clear all
NCT05704894 2023-01-30

Asses the Impact of Early Starting Erythropoetin in the Reduction of Transfusions Blood in Childrens

Blau Farmaceutica S.A.

Phase 3 Unknown
320 enrolled
Classical hematology

Anemia, Neoplasms

NCT03010579 2017-01-05

Erythropoietin in the Treatment of Anemia After Autologous Hematopoietic Stem Cell Transplantation

Peking University

Phase 4 Unknown
70 enrolled
Classical hematologyLymphoid

Anemia, Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡